Classically, GAPDH or ACTB were two of the most commonly used IRGs, but it is well known that these genes can exhibit significant variation in specific cells, tissues, and experimental conditions (such as the metabolic status and/or tumor presence) [15,26], highlighting the need for rigorous selection of IRGs for accurate gene expression analyses and reliable results. This evidence concerns the gene ACTB and neoplasm.